News
Get in Touch
Our Locations
Q² Solutions, HSBlox and R3 announce successful Proof-of-Concept of blockchain-based solution
Tracking of Human Biological Samples in Clinical ResearchQ² Solutions Announces Deployment of Next Generation Flow Cytometry Services
Q2 Solutions Globally Deploys 30+ Color Flow Cytometry CapabilityQ² Solutions | EA Genomics launches Illumina’s TruSight™ Oncology 500 Tumor Profiling assay services for the analysis of Tumor Mutational Burden
Morrisville, N.C. – April 8, 2019 – Q2 Solutions | EA Genomics launches Illumina’s TruSight™ Oncology 500 (TSO 500) next-generation sequencing (NGS) assay services for the analysis of key...Q² Solutions Expands Genomics Capabilities in Europe
Morrisville, NC – March 27, 2019 - Q2 Solutions, a leading clinical trial laboratory services organization, proudly announces the expansion of genomics capabilities in Edinburgh, Scotland, including...Q² Solutions and KingMed Partner to Develop In Vitro Diagnostics and Companion Diagnostics in China
Q2 Solutions and KingMed to Develop IVDs and CDx in ChinaQ² Solutions | EA Genomics receives New York State Clinical Laboratory Certification
Morrisville, NC - August 22, 2018 – Q2 Solutions | EA Genomics is proud to announce that it has received a Clinical Laboratory Certification from the New York State Department of Health in the...Q² Solutions Welcomes Michael Brown as Immunoanalytical Scientific Director and Site Lead
New immunoanalytical scientific leader brings more than 20 years of industry experienceQ² Solutions Expands Genomics Capabilities in China
Morrisville, N.C. – July 23, 2018 – Q2 Solutions proudly announces expanded genomics capabilities in China, leveraging more than 16 years of complex genomic testing experience, in addition to...Q² Solutions Expands Bioanalytical Capabilities in China
Morrisville, N.C. – July 11, 2018 – Q2 Solutions, a global clinical trials laboratory services organization, announced today the expansion of its bioanalytical capabilities in Beijing, China. This...